Neuberger Berman Group
ATRA icon

Neuberger Berman Group’s Atara Biotherapeutics ATRA Stock Holding History

Neuberger Berman Group’s Portfolio ATRA Stock Details ATRA Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-11,976
Closed -$8.31K – 1899
2024
Q1 		$8.31K Buy
11,976
+839
+8% +$582 ﹤0.01% 1817
2023
Q4 		$5.71K Buy
+11,137
New +$5.71K ﹤0.01% 1855
2019
Q4 		– Sell
-977,925
Closed -$13.8M – 1524
2019
Q3 		$13.8M Sell
977,925
-388,091
-28% -$5.48M 0.02% 660
2019
Q2 		$27.5M Buy
1,366,016
+59,365
+5% +$1.19M 0.03% 525
2019
Q1 		$51.9M Buy
1,306,651
+16,703
+1% +$664K 0.06% 388
2018
Q4 		$44.8M Buy
1,289,948
+71,409
+6% +$2.48M 0.06% 382
2018
Q3 		$50.4M Buy
1,218,539
+74,833
+7% +$3.09M 0.06% 407
2018
Q2 		$42M Buy
1,143,706
+49,225
+4% +$1.81M 0.05% 455
2018
Q1 		$42.7M Buy
1,094,481
+82,285
+8% +$3.21M 0.05% 444
2017
Q4 		$18.3M Sell
1,012,196
-102,845
-9% -$1.86M 0.02% 647
2017
Q3 		$18.5M Buy
1,115,041
+147,061
+15% +$2.43M 0.02% 631
2017
Q2 		$13.6M Buy
967,980
+131,465
+16% +$1.84M 0.02% 689
2017
Q1 		$17.2M Buy
836,515
+86,375
+12% +$1.77M 0.02% 633
2016
Q4 		$10.7M Buy
750,140
+61,425
+9% +$872K 0.01% 733
2016
Q3 		$14.7M Buy
688,715
+59,595
+9% +$1.27M 0.02% 672
2016
Q2 		$14.2M Buy
629,120
+96,750
+18% +$2.18M 0.02% 673
2016
Q1 		$10.1M Buy
532,370
+38,455
+8% +$732K 0.01% 747
2015
Q4 		$13M Buy
493,915
+20,245
+4% +$535K 0.02% 710
2015
Q3 		$14.9M Buy
473,670
+27,650
+6% +$869K 0.02% 703
2015
Q2 		$23.5M Sell
446,020
-757
-0.2% -$39.9K 0.03% 645
2015
Q1 		$18.6M Buy
446,777
+405,501
+982% +$16.9M 0.02% 715
2014
Q4 		$1.1M Buy
+41,276
New +$1.1M ﹤0.01% 1204